These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8719927)

  • 21. Atrial natriuretic peptide and hemodynamic changes after concentrated ascitic fluid reinfusion in cirrhotic patients.
    Messa P; Cannella G; Mioni G; Boscutti G; Messa M; De Biasi F; Cioni A
    Nephron; 1993; 65(1):67-72. PubMed ID: 8413794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal function.
    Trevisani F; Colantoni A; Gerbes AL; Gülberg V; Sica G; Caraceni P; De Notariis S; Morselli-Labate AM; Ligabue A; Gasbarrini G; Bernardi M
    J Hepatol; 1997 Apr; 26(4):808-15. PubMed ID: 9126793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
    J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma endothelin levels in cirrhotic subjects.
    Veglio F; Pinna G; Melchio R; Rabbia F; Panarelli M; Gagliardi B; Chiandussi L
    J Hepatol; 1992 May; 15(1-2):85-7. PubMed ID: 1387139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis.
    Uchihara M; Izumi N; Sato C; Marumo F
    Hepatology; 1992 Jul; 16(1):95-9. PubMed ID: 1535610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.
    Skorecki KL; Leung WM; Campbell P; Warner LC; Wong PY; Bull S; Logan AG; Blendis LM
    Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading].
    Horký K; Tesar V; Gregorová I; Srámková J; Dvoráková J
    Vnitr Lek; 1990 Jul; 36(7):625-32. PubMed ID: 2147304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.
    Bernardi M; Trevisani F; Santini C; De Palma R; Gasbarrini G
    Gut; 1983 Aug; 24(8):761-6. PubMed ID: 6347831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Gnädinger MP; Shaw S; Suchecka-Rachon K; Saxenhofer H
    Am J Nephrol; 1989; 9(4):291-9. PubMed ID: 2530903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of atrial natriuretic peptide resistance in cirrhosis with head-out water immersion and atrial natriuretic peptide infusion.
    Legault L; Warner LC; Leung WM; Logan AG; Blendis LM; Skorecki KL
    Can J Physiol Pharmacol; 1993 Feb; 71(2):157-64. PubMed ID: 8319139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis.
    Kojima H; Tsujimoto T; Uemura M; Takaya A; Okamoto S; Ueda S; Nishio K; Miyamoto S; Kubo A; Minamino N; Kangawa K; Matsuo H; Fukui H
    J Hepatol; 1998 May; 28(5):840-6. PubMed ID: 9625320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume.
    Saló J; Francitorra A; Follo A; Navasa M; Ginès A; Jiménez W; Ginès P; Arroyo V; Rivera F; Rodés J
    J Hepatol; 1995 Apr; 22(4):389-98. PubMed ID: 7665857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial natriuretic peptide-renin-aldosterone system in cirrhosis of the liver: circadian study.
    Colantonio D; Pasqualetti P; Casale R; Desiati P; Giandomenico G; Natali G
    Life Sci; 1989; 45(7):631-5. PubMed ID: 2528047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
    Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
    Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites.
    Saito I; Saruta T; Eguchi T; Nakamura R; Kondo K; Iyori S; Kato E
    Jpn Heart J; 1978 Sep; 19(5):741-7. PubMed ID: 731936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of captopril on renin and blood pressure in cirrhosis.
    Stanek B; Renner F; Sedlmayer A; Silberbauer K
    Eur J Clin Pharmacol; 1987; 33(3):249-54. PubMed ID: 3319647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function impairment induced by change in posture in patients with cirrhosis and ascites.
    Bernardi M; Santini C; Trevisani F; Baraldini M; Ligabue A; Gasbarrini G
    Gut; 1985 Jun; 26(6):629-35. PubMed ID: 3891534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aldosterone and renin in liver cirrhosis with ascites].
    Vetter H; Vetter W; Beckerhoff R; Glänzer K; Furrer J; Hahn C; Kolloch R; Krück F; Kutz K; Siegenthaler W; Witassek F
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1755-9. PubMed ID: 929137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
    Jespersen B; Jensen L; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.